Some medications combine a GLP-1 receptor agonist with insulin in a single daily injection
This equaled a weight loss of about 15%17%
Another challenge is that the approved drugs have experienced periods of limited availability owing to increased demand, such that these and other GLP-1-type drugs have been listed on the FDAs Drug Shortages list
JAMA has found a significant increase in numbers, which means you might qualify too
Food & Drug Administration (2024) Mounjaro- tirzepatide injection, solution, National Library of Medicine (2024) Weight loss efficiency and safety of tirzepatide: A systematic review, PLoS One (2023) Zepbound- tirzepatide injection, solution, National Library of Medicine (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Our local personal injury lawyers also serve clients in areas such as Denton, McKinney, Flower Mound, Plano, Carrollton, Garland, Mesquite, Irving, Arlington, Fort Worth, Waxahachie, Bastrop, Bellmead, Belton, Brenham, Buda, Caldwell, Georgetown, Harker Heights, Hearne, Kyle, Longview, Madisonville, McGregor, Navasota, New Braunfels, Pflugerville, Rockdale, Round Rock, San Antonio, San Marcos, and Temple.